C&D Emerging Investment has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Oricell Therapeutics's $120M Series B+ round in July 2022, alongside Suzhou Fund, Shanghai Sci-Tech Innovation Center Capital, Quan Capital and 3 others. That company is in Health and bio.

What C&D Emerging Investment invests in

• Health and bio · 1 · 100%

How C&D Emerging Investment invests

Share is of the 1 round on Recent Funding that name C&D Emerging Investment. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

C&D Emerging Investment portfolio companies

• OOricell Therapeutics$120MSeries B+ · Jul 2022

Most frequent co-investors

• QQiming Venture Partners1 shared round · last Jul 1, 2022
• SSuzhou Fund1 shared round · last Jul 1, 2022
• SShanghai Sci-Tech Innovation Center Capital1 shared round · last Jul 1, 2022
• QQuan Capital1 shared round · last Jul 1, 2022
• JJ One Capital1 shared round · last Jul 1, 2022
• BBoquan Equity Investment Management1 shared round · last Jul 1, 2022

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAlly Bridge Group1 company · 1 deal in 12 mo
• AAmadeus Capital Partners1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGeneration Ventures1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists C&D Emerging Investment, which is a subset of its real portfolio. API: /api/v1/investors/c-d-emerging-investment (get a free API key). More: the most active VC firms and new venture capital funds.